Oxothiazolidine carboxylate - Triage Therapeutics
Latest Information Update: 16 Jul 2016
At a glance
- Originator University of Saskatchewan
- Class Reducing agents; Small molecules
- Mechanism of Action Antioxidants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Craniocerebral trauma; Spinal cord injuries
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Craniocerebral-trauma in USA
- 16 Jul 2016 No recent reports of development identified for preclinical development in Spinal-cord-injuries in USA
- 20 Aug 2003 Preclinical trials in Head injuries in USA (unspecified route)